Similar articles

• Research accountability and financial conflicts of interest in industry-sponsored clinical research: a review.

  Tereskerz PM. Tereskerz PM. Account Res. 2003 Jul-Sep;10(3):137-58. doi: 10.1080/714906093. Account Res. 2003. PMID: 14979317 No abstract available.
• Financial disclosure for review authors.

  [No authors listed] [No authors listed] Nat Neurosci. 2003 Oct;6(10):997. doi: 10.1038/nn1003-997. Nat Neurosci. 2003. PMID: 14513027 No abstract available.
• Editorial policies on financial disclosure.

  Carroll BJ, Rubin RT. Carroll BJ, et al. Nat Neurosci. 2003 Oct;6(10):999-1000; author reply 1000-1. doi: 10.1038/nn1003-999. Nat Neurosci. 2003. PMID: 14513028 No abstract available.
• [Conflict of interest viewed from over-sea reports regarding relationship between clinical psychiatry and drug industry].

  Senba J. Senba J. Seishin Shinkeigaku Zasshi. 2010;112(11):1124-9. Seishin Shinkeigaku Zasshi. 2010. PMID: 21351692 Review. Japanese. No abstract available.
• Current controversies in prenatal diagnosis 4: does industry-sponsorship accelerate or hinder the pace of research?

  Sterckx S, Worthington G, Van Steirteghem A. Sterckx S, et al. Prenat Diagn. 2011 Mar;31(3):244-5. doi: 10.1002/pd.2700. Epub 2011 Feb 16. Prenat Diagn. 2011. PMID: 21374638 Review. No abstract available.